ArticlebioRxiv : the preprint server for biology2025
Repression of PRMT activities sensitize homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatment.
Youyou Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.